Comparative genomic hybridization is a molecular-cytogenetic method for the analysis of regional changes in the DNA content of tumor cells. The method is based on the hybridization of fluorescently labeled tumor and normal DNA to normal human metaphase preparations. Using epiflourescence microscopy and quantitative image analysis, regional differences in the fluorescence ratio of tumor vs. control DNA can be detected and used for identifying abnormal regions in the tumor cell genome.